Biology-guided adaptive radiation therapy presence or future?

Acta Oncologica

Volumn 49, Issue 7, 2010, Pages 884-887

  Grau, Cai ^a   Olsen, Dag Rune ^b   Overgaard, Jens ^a   Høyer, Morten ^a   Lindegaard, Jacob Christian ^a   Muren, Ludvig Paul ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADAPTATION; BREAST CANCER; CANCER RADIOTHERAPY; EDITORIAL; HYPOXIA; MEDICAL EDUCATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN ENHANCEMENT RATIO; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; RADIOSENSITIVITY; SENTINEL LYMPH NODE BIOPSY; STEREOTACTIC BODY RADIATION THERAPY;

ADAPTATION, BIOLOGICAL; BIOLOGY; DOSE FRACTIONATION; FLUORODEOXYGLUCOSE F18; HUMANS; RADIATION ONCOLOGY; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; SURGERY, COMPUTER-ASSISTED;

EID: 77956565074     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2010.516010     Document Type: Editorial

References (42)

1. Overgaard J. Management of the axilla in breast cancer. Implication for diagnosis, prognosis, treatment, and morbidity. Acta Oncol 2000;39:259-260
2. Levitt S. Second Acta Oncologica symposium on prostate cancer controversies. Acta Oncol 2005;44:526-528
3. Grau C, Høyer M, Lindegaard J, Overgaard J. The emerging evidence for Stereotactic Body Radiotherapy. Acta Oncol 2006;45: 771-774
4. Høyer M, Roed H, Traberg Hansen A, Ohlhuis L, Petersen J, Nellemann H, et al. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 2006; 45:823-830
5. Paludan M, Traberg Hansen A, Petersen J, Grau C, Høyer M. Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency? Acta Oncol 2006;45: 818-822
6. Baumann P, Nyman J, Lax I, Friesland S, Høyer M, Rehn Ericsson S, et al. Factors important for efficacy of stereotac-tic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 2006;45:787-795
7. Nord C, Ganz PA, Aziz N, Fosså SD. Follow-up of longterm cancer survivors in the Nordic countries. Acta Oncol 2007;46: 433-440
8. Aziz NM. Cancer survivorship research: State of knowledge, challenges and opportunities. Acta Oncol 2007;46:417-432
9. Overgaard J. DBCG: The Danish Breast Cancer Cooperative Group-a 30-year struggle for better breast cancer treatment in Denmark. Acta Oncol 2008;47:491-496
10. Grau C, Muren LP, Høyer M, Lindegaard JC, Overgaard J. Image-guided adaptive radiotherapy-integration of biology and technology to improve clinical outcome. Acta Oncol 2008;47:1182-1185
11. Nielsen T, Mouridsen K, Maxwell RJ, Stødkilde-Jørgensen H,østergaard L, Horsman MR. Segmentation of dynamic contrast enhanced magnetic resonance imaging data. Acta Oncol 2008;47:1265-1270
12. østergaard Noe K, De Senneville B, Elstrøm U, Tanderup K, Sørensen TS. Acceleration and validation of optical flow based deformable registration for image-guided radiotherapy. Acta Oncol 2008;47:1286-1293
13. Pötter R, Kirisits C, Fidarova EF, Dimopoulos JCA, Berger D, Tanderup K, et al. Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma. Acta Oncol 2008;47:1325-1336
14. Wright P, Redpath A, Høyer M, Grau C, Muren LP. The normal tissue sparing potential of adaptive strategies in radiotherapy of bladder cancer. Acta Oncol 2008;47: 1382-1389
15. Muren LP, Petersen JB, Hansen J, Hafslund R. Medical physics in the Nordic countries: The past, the present and the future. Acta Oncol 2009;48:165-168
16. Webb S. The contribution, history, impact and future of physics in medicine. Acta Oncol 2009;48:169-177
17. Jeraj R. Future of physics in medicine and biology. Acta Oncol 2009;48:178-184
18. Søndergaard J, Høyer M, Petersen JB, Wright P, Grau C, Muren LP. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy. Acta Oncol 2009;48: 238-244
19. Andreassen, CN, Alsner, J. Genetic variants and normal tissue toxicity after radiotherapy: A systematic review. Radi-other Oncol 2009;92:299-309.
20. Ishkanian AS, Zafarana G, Thoms J, Bristow RG. Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer. Acta Oncol 2010;49:888-894
21. Busk M, Horsman MR, Overgaard J. Resolution in PET hypoxia imaging: Voxel size matters. Acta Oncol 2008;47: 1201-1210
22. Brock KK, Hawkins M, Eccles C, Moseley JL, Moseley DJ, Jaffray, DA, et al. Improving image-guided target localization through deformable registration. Acta Oncol 2008;47: 1279-1285
23. Newbold KL, Partridge M, Cook G, Sharma B, Rhys-Evans P, Harrington, KJ, et al. Evaluation of the role of 18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer. Acta Oncol 2008; 47:1229-1236
24. Roels S, Slagmolen P, Nuyts J, Lee JA, Loeckx D, Maes F, et al. Biological image-guided radiotherapy in rectal cancer: Is there a role for FMISO or FLT, next to FDG?. Acta Oncol 2008;47:1237-1248
25. Busk M, Munk OL, Jakobsen S, Wang T, Skals M, Steiniche T, et al. Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET. Acta Oncol 2010;49:922-933
26. Røe K, Aleksandersen TB, Kristian A, Nilsen LB, Seierstad T, Qu H, et al. Preclinical dynamic 18F-FDG PET-tumor characterization and radiotherapy response assessment by kinetic compartment analysis. Acta Oncol 2010;49: 914-921
27. Nielsen T, Murata R, Maxwell RJ, Stødkilde-Jørgensen H,østergaard L, Ley CD, et al. Non-invasive imaging of com-bretastatin activity in two tumour models: Association with invasive estimates. Acta Oncol 2010;49:906-913
28. Søvik Å, Kippenes Skogmo H, Bruland S, Olsen DR, Malinen E. DCEMRI monitoring of canine tumors during fractionated radiotherapy. Acta Oncol 2008;47:1249-1256
29. Haack S, Morre-Pedersen E, Jespersen SN, Kallehauge JF, Lindegaard JC, Tanderup K. Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer. Acta Oncol 2010;49:978-983
30. Kallehauge JF, Tanderup K, Haack S, Nielsen T, Fokdal L, Lindegaard JC, et al. Apparent diffusion coefficient (ADC) as a quantitative parameter in diffusion weighted MR imaging in gynecologic cancer: Dependence on b-values used. Acta Oncol 2010;49:1017-1022
31. Van Herk M. Will IGRT live up to its promise? Acta Oncol 2008;47:1186-1187
32. Verellen D, De Ridder M, Tournel K, Duchateau M, Rey-nders T, Gevaert T, et al. An overview of volumetric imaging technologies and their quality assurance for IGRT. Acta Oncol 2008;47:1271-1278
33. Baumann M, Hölscher T, Zips D. The future of IGRT-Cost benefit analysis. Acta Oncol 2008;47:1188-1192
34. Vestergaard A, Søndergaard J, Petersen JB, Høyer M, Muren L P. A comparison of three different adaptive strategies in image-guided radiotherapy of bladder cancer. Acta Oncol 2010;49:1069-1076
35. Gottlieb KL, Hansen CR, Hansen O, Westberg J, Brink C. Investigation of respiration induced intra-and inter-fractional tumour motion using a standard Cone Beam CT. Acta Oncol 2010;49:1192-1198
36. Elstrøm UV, Wysocka BA, Muren LP, Petersen JB, Grau C. Daily KV cone-beam CT and deformable image registration as a method for studying dosimetric consequences of anatomic changes in adaptive IMRT of head and neck cancer. Acta Oncol 2010;49:1101-1108
37. Røthe Arnesen M, Eilertsen K, Malinen E. Optimal treatment margins for radiotherapy of prostate cancer based on interfraction imaging. Acta Oncol 2008;47:1373-1381
38. Bedford JL, Hansen VN, McNair HA, Aitken AH, Brock JEC, Warrington AP, et al. Treatment of lung cancer using volumetric modulated arc therapy and image guidance: A case study. Acta Oncol 2008;47:1438-1443
39. Korreman S, Medin J, Kjær-Kristoffersen F. Dosimetric Verification of RapidArc treatment delivery. Acta Oncol 2009;48:185-191
40. Kjær-Kristoffersen F, Ohlhues L, Medin J, Korreman S. RapidArc volumetric modulated therapy planning for prostate cancer patients. Acta Oncol 2009;48:227-232
41. Deveau M, Bowen SR, Westerly DC, Jeraj R. Feasibility and sensitivity study of helical tomotherapy for dose painting plans. Acta Oncol 2010;49:991-996
42. William Gibson, in NPR Talk of the Nation (30 November 1999).